Showing results (341-350 of 374) with videos related to

Sort By:
Pageof 38
Journal of Cancer|June 22, 2026
Association between obesity, sex, medical comorbidities, and survival in cancer patients treated with immune checkpoint inhibitorsMingjia Li, Daniel J Spakowicz, Songzhu Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2024
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, et al.
Clinical Lung Cancer|February 8, 2022
Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not ChemoimmunotherapyYizhen Guo, Lai Wei, Sandip H Patel, et al.
International Journal of Molecular Sciences|July 14, 2023
Metabolic Dysregulation Explains the Diverse Impacts of Obesity in Males and Females with Gastrointestinal CancersSpencer R Rosario, Bowen Dong, Yali Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2024
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 20, 2021
Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immune Checkpoint InhibitorsAngel Qin, Songzhu Zhao, Abdul Miah, et al.
Cancer Immunology, Immunotherapy : CII|March 9, 2026
Impact of proton pump inhibitors on immunotherapy is modulated by prior chemotherapy and linked to gut microbiome-immune cell signaturesAnnastasia Petouhoff, Ryan Hicks, Marium Husain, et al.
Frontiers in Immunology|January 2, 2026
Tumor intrinsic properties dictate Fc receptor expression and cancer cachexia associated increase in checkpoint inhibitor clearanceBryan C Remaily, Greg Young, Hannah Lathrop, et al.
Human Genetics|January 7, 2018
The CAPOS mutation in ATP1A3 alters Na/K-ATPase function and results in auditory neuropathy which has implications for managementLisbeth Tranebjærg, Nicola Strenzke, Sture Lindholm, et al.
Human Genetics|February 14, 2018
Correction to: The CAPOS mutation in ATP1A3 alters Na/K-ATPase function and results in auditory neuropathy which has implications for managementLisbeth Tranebjærg, Nicola Strenzke, Sture Lindholm, et al.
Pageof 38